Antipsychotics and the risk of diabetes and death among adults with serious mental illnesses.
Jason PoulosSharon-Lise T NormandKatya ZelevinskyJohn W NewcomerDenis AgnielHaley K AbingMarcela Horvitz-LennonPublished in: Psychological medicine (2023)
Haloperidol's, olanzapine's, and risperidone's lower diabetes risks relative to aripiprazole were not robust in sensitivity analyses but quetiapine's higher mortality risk proved robust. Findings expand the evidence on antipsychotics' risks, suggesting a need for caution in the use of quetiapine among individuals with SMI.